FDA
approval
· 2022-07-15
FDA Approved: TERIFLUNOMIDE — Supplemental Application (Accord Healthcare Inc.)
Summary
FDA approved a supplemental application for Accord Healthcare Inc.'s Teriflunomide, finalizing regulatory action on the generic product.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for TERIFLUNOMIDE (TERIFLUNOMIDE)